Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • Medical Jobs
  • Medical Matrimony
  • MD Brand Connect
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • MCI News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Aborad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • MCI News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Aborad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • empagliflozin

Tag: empagliflozin

You Searched For "empagliflozin"
Empagliflozin use feasible for HFpEF patients whether or not they are taking diuretics: JAMA

Empagliflozin use feasible for HFpEF patients whether or not they are taking diuretics: JAMA

Medha Baranwal29 May 2023 5:45 AM GMT
USA: Empagliflozin treatment in patients with heart failure and preserved ejection fraction (HFpEF) is similar regardless of diuretic dose or use; and...
Empagliflozin reduces heart failure events across spectrum of CKD: Analysis of EMPEROR trials

Empagliflozin reduces heart failure events across spectrum of CKD: Analysis of EMPEROR trials

Medha Baranwal11 May 2023 5:15 AM GMT
USA: Empagliflozin (Jardiance) consistently reduced heart failure (HF) events across the spectrum of chronic kidney disease (CKD), according to...
Eli Lilly-Boehringers Jardiance for children with type 2 diabetes accepted by USFDA

Eli Lilly-Boehringer's Jardiance for children with type 2 diabetes accepted by USFDA

Ruchika Sharma10 March 2023 6:53 AM GMT
Indianapolis: Boehringer Ingelheim and Eli Lilly and Company have announced that the U.S. Food and Drug Administration (FDA) has accepted a...
Empagliflozin tied to meaningful reduction of HbA1c compared to linagliptin in young diabetes patients: Lancet

Empagliflozin tied to meaningful reduction of HbA1c compared to linagliptin in young diabetes patients: Lancet

Jacinthlyn Sylvia9 March 2023 5:45 AM GMT
A new study published in The Lancet Diabetes & Endocrinology suggests that linagliptin did not reduce HbA1c in a clinically meaningful way,...
SGLT2 inhibitor empagliflozin could be new treatment option for children with type 2 diabetes: Lancet

SGLT2 inhibitor empagliflozin could be new treatment option for children with type 2 diabetes: Lancet

Dr. Kamal Kant Kohli4 March 2023 5:30 AM GMT
USA: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, findings from a phase 3 clinical trial have...
Medical Bulletin 25/February/2023

Medical Bulletin 25/February/2023

Isra Zaman25 Feb 2023 9:15 AM GMT
Here are the top medical news for the day: Oral empagliflozin provided safe glycemic control in children with type 2 diabetes: Phase 3 trial...
Oral empagliflozin provided safe glycemic control in children with type 2 diabetes: Phase 3 trial findings

Oral empagliflozin provided safe glycemic control in children with type 2 diabetes: Phase 3 trial findings

Isra Zaman25 Feb 2023 3:30 AM GMT
Researchers led by pediatric endocrinologists at Joslin Diabetes Center recently completed a phase 3 clinical trial that assessed the efficacy and...
Empagliflozin promising in hyponatremia induced by Chronic Syndrome of Inappropriate Antidiuresis

Empagliflozin promising in hyponatremia induced by Chronic Syndrome of Inappropriate Antidiuresis

Dr Kartikeya Kohli10 Feb 2023 6:00 AM GMT
Switzerland: According to clinical research on acid-base and electrolyte disorders, the sodium-glucose cotransporter 2 (SGLT2) inhibitor...
USFDA accepts supplemental New Drug Application for Jardiance for adults with chronic kidney disease: Eli Lilly

USFDA accepts supplemental New Drug Application for Jardiance for adults with chronic kidney disease: Eli Lilly

Ruchika Sharma22 Jan 2023 6:30 AM GMT
Indianapolis: The U.S. Food and Drug Administration (USFDA) has accepted a supplemental New Drug Application (sNDA) for Jardiance (empagliflozin)...
Torrent Pharma collaborates with Boehringer Ingelheim India to co-market its anti-diabetic drug, its fixed dose combinations in India

Torrent Pharma collaborates with Boehringer Ingelheim India to co-market its anti-diabetic drug, its fixed dose combinations in India

Ruchika Sharma14 Dec 2022 11:20 AM GMT
Ahmedabad: Torrent Pharmaceuticals Ltd has entered into a strategic alliance with Boehringer Ingelheim India Private Limited to co-market Cospiaq...
Empagliflozin improves outcomes in HF with preserved EF irrespective of BP: the EMPEROR-Preserved trial

Empagliflozin improves outcomes in HF with preserved EF irrespective of BP: the EMPEROR-Preserved trial

Medha Baranwal13 Dec 2022 5:00 AM GMT
Germany: Empagliflozin reduces the risk of heart failure (HF) hospitalization or cardiovascular (CV) death in HRpEF (heart failure and preserved...
Empagliflozin as add-on therapy improves quality of life in diabetes patients

Empagliflozin as add-on therapy improves quality of life in diabetes patients

Medha Baranwal28 Nov 2022 4:45 AM GMT
Punjab: Empagliflozin can be recommended as an add-on medication in type 2 diabetes (T2D) patients with hypertension with regards to improving their...
Next

Editorial

Journal Club Today

Health News Today

© 2022 All Rights Reserved.
Powered By: Hocalwire
X
X